User talk:SamNCL

Your submission at Articles for creation: Sterling Pharma Solutions (January 15)
 Your recent article submission to Articles for Creation has been reviewed. Unfortunately, it has not been accepted at this time. The reason left by S0091 was:

The comment the reviewer left was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.


 * If you would like to continue working on the submission, go to Draft:Sterling Pharma Solutions and click on the "Edit" tab at the top of the window.
 * If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
 * If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk/New_question&withJS=MediaWiki:AFCHD-wizard.js&page=Draft:Sterling_Pharma_Solutions Articles for creation help desk], on the [//en.wikipedia.org/w/index.php?title=User_talk:S0091&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:Sterling_Pharma_Solutions reviewer's talk page] or use Wikipedia's real-time chat help from experienced editors.

S0091 (talk) 18:44, 15 January 2024 (UTC)


 * Hi S0091,
 * This article follows the style and types of sources used by other pharmaceutical companies, such as Cambrex Corporation and Lonza Group who's references are mostly their own websites and press press releases. Is the referencing acceptable in these articles acceptable but not in this one? This seems inconsistent and is confusing as these companies both have Wikipedia articles. Please could you advise on this specifically?
 * Thank you,
 * SamNCL SamNCL (talk) 13:57, 13 March 2024 (UTC)

March 2024
Hello SamNCL. The nature of your edits gives the impression you have an undisclosed financial stake in promoting a topic, but you have not complied with Wikipedia's mandatory paid editing disclosure requirements. Paid advocacy is a category of conflict of interest (COI) editing that involves being compensated by a person, group, company or organization to use Wikipedia to promote their interests. Undisclosed paid advocacy is prohibited by our policies on neutral point of view and what Wikipedia is not, and is an especially serious type of COI; the Wikimedia Foundation regards it as a "black hat" practice akin to black-hat search-engine optimization.

Paid advocates are strongly discouraged from direct article editing, and should instead propose changes on the talk page of the article in question if an article exists. If the article does not exist, paid advocates are strongly discouraged from attempting to write an article at all. At best, any proposed article creation should be submitted through the articles for creation process, rather than directly.

Regardless, if you are receiving or expect to receive compensation for your edits, broadly construed, you are  required by the Wikimedia Terms of Use to disclose your employer, client and affiliation. You can post such a mandatory disclosure to your user page at User:SamNCL. The template Paid can be used for this purpose – e.g. in the form:. If I am mistaken – you are not being directly or indirectly compensated for your edits – please state that in response to this message. Otherwise, please provide the required disclosure. In either case, do not edit further until you answer this message. 331dot (talk) 14:10, 13 March 2024 (UTC)